Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 301 - 350 out of 9,656

Document Document Title
WO/2011/123890A1
The invention relates to novel compounds, processes for their preparation and their use in protecting biological materials from radiation damage (radioprotection). Preferred compounds of the invention are those of Formula (II), as follow...  
WO/2011/117690A1
The present invention relates to the use of hydroxyl-2, 3- diarylxanthones (DAX) as therapeutic agent of pathologies due to reactive oxygen species. Certain polyhydroxy-2, 3-diaryl-9H-xanthen-9-ones present antioxidant properties much hi...  
WO/2011/116216A2
Topical skin care compositions containing a combination of ascorbic acid or a derivative thereof, brown algae extract, and a blend of botanical extracts comprising cucumber extract, watercress extract, birch leaf extract, red clover extr...  
WO/2011/113300A1
Compounds of formula (1) or a derivative thereof, acipimox, are used in combination with several chemotherapeutic agents for inhibition of toxicity or side effects caused by chemotherapeutic agents, while do not attenuate chemotherapeuti...  
WO/2011/110661A1
An antioxidant composition is described for reducing oxidative stress in subjects undergoing hormonal contraceptive drug treatment. In particular, said composition has proved to be particularly suitable because, as well as being surprisi...  
WO/2011/111577A1
Provided is an adsorption carbon which can effectively adsorb toxins, such as advanced glycation end-products (AGEs), within a living body. Also provided is an adsorbent which contains said adsorption carbon as the active ingredient. The...  
WO/2011/107877A3
A compound, composition and method of making and using a compound of formula (1) are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The com...  
WO/2011/107870A3
A compound, composition, method of synthesizing and using the compound of formula (I) are disclosed. The compound of formula (I) also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharm...  
WO/2011/107259A1
The subject invention relates to a chocolate or compound chocolate product comprising added functional ingredients including vitamin C, vitamin E, zinc, copper and, optionally, a xanthophyll. The invention further concerns the production...  
WO/2011/107867A3
A compound, composition and method of making and using a compound of formula (1) are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, mesylates, hydrochloric salt, solvates and hydrates thereof. The com...  
WO/2011/107881A3
A compound, composition, method of synthesizing and using the compound of formula 1 are disclosed. The compound of formula I also comprises of salts, polymorphs, solvates, and hydrates thereof. The compound may be formulated as pharmaceu...  
WO/2011/105424A1
The purpose of the present invention is to find a ligand for a DCIR and to search for a stimulant and an antagonist for the DCIR. Specifically disclosed are: a dendritic cell immunoreceptor stimulant which contains keratan sulfate II (KS...  
WO/2011/102310A1
Disclosed is a blood uric acid level lowering agent, which is derived from a natural material and can be ingested continuously for a long period. The blood uric acid level lowering agent comprises an enzymatic decomposition product of a ...  
WO/2011/103536A1
The present disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such...  
WO/2011/099031A1
This invention is based on strong antioxidants which are useful for all age group. The basic composition of ingredients are-EPA 150 mg, DHA 100 mg, Folic Acid 5 mg and Lycopene 50 mg. DHA is a major fatty acid in sperm and brain phosphol...  
WO/2011/099526A1
Disclosed is a biocompatible solution which can deliver a sufficient quantity of hydrogen molecules into cells. Specifically disclosed is a hydrogen-containing hypotonic biocompatible solution which contains hydrogen molecules, contains ...  
WO/2011/097372A3
Cocrystals of pterostilbene are disclosed, including: pterostilbene: caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene : glutaric acid cocrystal, and pterostilbene: piperazine cocrystal. The pterostilbene: caffeine...  
WO/2011/097372A2
Cocrystals of pterostilbene are disclosed, including: pterostilbene: caffeine cocrystal, pterostilbene:carbamazepine cocrystal, pterostilbene : glutaric acid cocrystal, and pterostilbene: piperazine cocrystal. The pterostilbene: caffeine...  
WO/2011/092290A1
There are described 4-difluoromethoxyphenyl pyrazolo[5.1-b]oxazole derivatives useful as corticotropin releasing factor (CRF1) receptor antagonists.  
WO/2011/093469A1
Promotion of the expression of a redox-related factor in a living organism ensures safe and efficient reduction of oxidative stress in the organism, contributes to the maintenance of good health and prevents various diseases and symptoms...  
WO/2011/089951A1
Disclosed are a prevention/treatment agent for diabetic retinopathy characterized by containing lutein; said prevention/treatment agent, an ameliorating agent for an electroretinogram, an apoptosis suppression agent for retinal ganglion ...  
WO/2011/091357A1
The disclosure provides aromatic-cationic peptide compositions and methods of preventing or treating disease using the same. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to subject...  
WO/2011/080139A1
The present invention relates to amino alcohol derivatives of general formula (I). These derivatives possess an interesting activity in that they block the secondary products of lipid oxidative stress, and are consequently suitable for t...  
WO/2011/078785A1
The present invention relates to novel compounds, and in particular to diacylglycerol (1, 3-DAG) and alpha-lipoic acid (LA) and/or dihydro-alpha-lipoic acid (DHLA) derivatives. In particular these novel compounds are used as functional f...  
WO/2011/079212A3
Provided herein are methods of culturing cells in vitro in order to exploit the biochemical production ability of the cells to make metabolites that are evaluated and harvested for their biological effects. Also provided are systems for ...  
WO/2011/067653A1
The invention refers to a composition to treat or prevent in subjects with sub-clinical or acute mercury intoxication from dental amalgam, or a diagnostic tool thereof. The odontostamatologic composition comprising at least a non-resorba...  
WO/2011/059021A1
Disclosed is a compound represented by formula (1) or a pharmacologically acceptable salt thereof. (In the formula, A represents a group that is represented by formula (A-1); R1a and R1b may be the same or different and each independentl...  
WO/2011/059416A1
The invention relates to pharmacology, medicine, livestock breeding and poultry farming, and is directed towards producing agents and methods which can be used for prophylactic aims in order to reduce the risk of morbidity caused by nega...  
WO/2011/059733A3
The present invention provides lipoic acid or derivatives thereof for use in graft stabilization of fat grafts. Mixing of lipoic acid or a derivative thereof with adipocytes or adipose tissue to be transplanted into a subject leads to mo...  
WO/2011/058773A1
Disclosed is a composition which is capable of stably containing a carotenoid for a long period of time. The composition is characterized by containing (A) a carotenoid, (B) a middle chain saturated fatty acid triglyceride and (C) tocotr...  
WO/2011/056234A1
The present invention relates to methods and medicaments useful for treatment of radiation-induced disorders by administering anti-CTGF agents, particularly anti-CTGF antibodies. Methods and medicaments for pre-treating individuals havin...  
WO/2011/055869A1
The present invention relates to a therapeutic agent for diabetic complications and a treatment method for diabetic complications using the same, and more specifically, to an agent for prevention and treatment of diabetic complications c...  
WO/2011/050152A3
Methods and compositions for site-specific modification of amino acids, peptides, polypeptides and proteins are disclosed.  
WO/2011/049484A1
The invention relates to the chemico-pharmaceutical industry, specifically to the production of an antioxidant. The antioxidant comprises the following ingredients: flower pollen, dihydroquercetin, vitamin С, vitamin E, honeybee royal j...  
WO/2011/050152A2
Methods and compositions for site-specific modification of amino acids, peptides, polypeptides and proteins are disclosed.  
WO/2011/046199A1
Provided are a component, which not only has an ability to reduce oxidized coenzyme Q10 and an ability to stabilize reduced coenzyme Q10 but also contains nutrients and has a good taste and broad utility, and a method for using the same....  
WO/2011/044701A1
Described herein are isolated polypeptides having phosphatase and tensin homolog (PTEN) inhibitory activity, vectors and cells for the expression thereof and methods for their use in treating a diseases associated with cytotoxic stress, ...  
WO/2011/045934A1
Provided are a component, which not only has an ability to reduce oxidized coenzyme Q10 and an ability to stabilize reduced coenzyme Q10 but also contains nutrients and has a good taste and broad utility, and a method for using the same....  
WO/2011/037467A1
The invention relates to Atazanavir for use as a medicament for preventing, treating and/or delaying an inflammation-mediated or -associated disease and/or a disease wherein oxidative stress occurs.  
WO/2011/038385A2
Sulfur-containing ligands and methods of their utilization for binding metals and/or main group elements and removing them from fluids, solids, gases and/or tissues are disclosed. The ligands are of the general structure (A): or structur...  
WO/2011/038385A9
Sulfur-containing ligands and methods of their utilization for binding metals and/or main group elements and removing them from fluids, solids, gases and/or tissues are disclosed. The ligands are of the general structure (A): or structur...  
WO/2011/037099A1
The purpose of the present invention is to further improve the hangover symptom-relieving effect of a composition comprising a Curcuma longa extract. More specifically, the purpose of the invention is to provide a composition by which sp...  
WO/2011/038385A3
Sulfur-containing ligands and methods of their utilization for binding metals and/or main group elements and removing them from fluids, solids, gases and/or tissues are disclosed. The ligands are of the general structure (A): or structur...  
WO/2011/033717A1
Disclosed are a goya (Momordica charantia L. var. pavel Crantz) koji composition, which is obtained by fermenting goya, that is an inexpensive and easily available material, with a koji mold, has elevated antioxidative and ACE-inhibitory...  
WO/2011/028673A2
Disclosed herein is a composition for delaying cellular senescence comprising from about 0.01 wt% to about (5) wt% of Hexapeptide-11(Phe-Val-Ala-Pro-Phe-Pro), based on the total weight of the composition, and a dermatologically-acceptabl...  
WO/2011/023653A1
The invention relates to a method for treating an overdosing with active substance dabigatran etexilate of formula I optionally in the form of the pharmaceutically acceptable salts thereof, comprising the administration of an effective a...  
WO/2011/025019A1
Disclosed is a lactic acid bacterium that is suitable for foods, beverages, and medicines, induces thioredoxin, and is capable of preventing/and or ameliorating a variety of biological damage resulting from oxidative stress. Also disclos...  
WO/2011/021218A3
An improved process for preparing 4-[3, 5-bis (2-hydroxyphenyl)-l, 2, 4-tπazol-l -yl] benzoic acid of formula-1 and a process for its purification are provided The preparation process comprises reacting salicylic acid with salicylamide ...  
WO/2011/018885A1
Disclosed are: a skin whitening agent which has an excellent skin whitening activity and can exhibit an excellent effect on the reduction in pigment deposition after sunburn, pigmented spots, freckles, chloasma or the like and the whiten...  
WO/2011/016459A1
Disclosed is a compound which has serotonin 5-HT2C receptor activating activity. Specifically disclosed is a compound represented by formula (I) or a salt thereof. (In the formula, the symbols are as defined in the description.)  

Matches 301 - 350 out of 9,656